CXCL8 and neoplasm: The study revealed that CA-MSCs highly express CXCR1/2 ligands such as CXCL1, CXCL2, and IL-8, which promote monocyte differentiation towards a pro-tumor M2 phenotype, facilitating tumor progression and the acquisition of chemotherapy resistance.